GFS Advisors, LLC

Position in CRSP — CRISPR Therapeutics AG

CIK 1427263 HOUSTON, TX

Position in CRSP

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$818

-$593,807 QoQ

Shares Held

-99.9% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#478

of 519 holders

Holding Since

Mar 2026

2 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

GFS Advisors, LLC holds $62,285 across 5 Biotechnology names. CRSP ranks #5 (1.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RXRX	Recursion Pharmaceuticals, Inc.	10,000	$36,700
2	MRNA	Moderna, Inc.	75,981	$11,345
3	REGN	Regeneron Pharmaceuticals, Inc.	18	$11,223
4	NTLA	Intellia Therapeutics, Inc.	130	$2,199
5	CRSP	CRISPR Therapeutics AG This page	15	$818

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$818	15	-99.9%	Shares	Sole	2026-08-13
2026-03-31	$594,625	12,500	—	Shares	Sole	2026-04-30
No filing history on record for this holder in this stock.